Buprenorphine Hydrochloride Market
Buprenorphine Hydrochloride Market Global Industry Assessment & Forecast
#
Pages:
155
2021
Nov - 2021
VMR-2021-0529
Segments Covered
By
Type Tablets, Injection
-
By
Application Analgesic, Opioid Antagonist
Snapshot
 Forecast
Years:
|
2021 - 2028 |
 Historical
Years:
|
2016 - 2020 |
 Revenue
2021: |
5.05 Billion |
 Revenue 2028:
|
9.49 Billion |
 Revenue CAGR
(2021 - 2028): |
8.2 |
Fastest Growing Region (2022 -
2028)
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
FAQ
Frequently Asked Question
What is the global demand for Buprenorphine Hydrochloride in terms of revenue?
-
The global Buprenorphine Hydrochloride valued at 5.05 Billion in 2020 and is expected to reach 9.49 Billion in 2028 growing at a CAGR of 8.2%.
Which are the prominent players in the market?
-
The prominent players in the market are Resonance-labs, UnichemlabsNoramco, Siegfried, Faranshimi, Johnson Matthey, Rusan Pharma, Mallinckrodt, Sanofi, Sun Pharma, Mocind, Sinopharm, Arevipharma..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 8.2% between 2021 and 2028.
What are the driving factors fueling the growth of the market?
-
The driving factors of the Buprenorphine Hydrochloride include
- The increasing opioid addiction cases are driving the growth of the buprenorphine hydrochloride market within estimated timeframe. With this, the number of reported cases of opioid addiction is increasing due to the high availability and low cost of opioids that is also likely to support the growth of the market.
- The increasing innovations and development by government in healthcare sector is expected to hinder the growth of the market in the years to come.
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Buprenorphine Hydrochloride in 2020.
